Phospho-Raf1 (S259) Recombinant Rabbit Monoclonal Antibody [SD85-07]
Usd: 385 Special Discount
Specification
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ET1612-87_Europe.pdf
- No MSDS Found
Overview
Product Name
Phospho-Raf1 (S259) Recombinant Rabbit Monoclonal Antibody [SD85-07]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic phospho-peptide corresponding to residues surrounding Ser259 of Human Raf1 aa 236-285 / 648.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IHC-P, IF-Cell, FC
Target Molecular Weight
Predicted band size: 73 kDa
Positive Control
HEK-293 cell lysate, HeLa cell lysate, NIH/3T3 cell lysate, C6 cell lysate, HEK-293, human skeletal muscle tissue, mouse skeletal muscle tissue, rat skeletal muscle tissue, human testis tissue, human tracheal tissue.
Conjugation
unconjugated
Clone Number
SD85-07
RRID
Reactivity Data
Verified (internally validated)
Reported in literature (not internally validated)
Predicted reactive (based on sequence homology)
Not recommended (failed internal validation)
| WB | IHC-P | FC | IF-Cell | |
|---|---|---|---|---|
| human |
|
|
|
|
| mouse |
|
|
|
|
| rat |
|
|
|
|
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.1% BSA, 40% Glycerol, 0.2% Proclean 950.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000
-
IHC-P
-
1:400-1:1,000
-
IF-Cell
-
1:100
-
FC
-
1:1,000
Target
Function
Raf-1 is a ubiquitously expressed cytoplasmic protein with intrinsic serine/threonine kinase activity. Raf-1, or c-Raf, is the cellular homolog of v-Raf, the product of the transforming gene of the 3611 strain of murine sarcoma virus. The unregulated kinase activity of the v-Raf protein is associated with cellular transformation and mitogenesis. Raf-1 is normally suppressed by its regulatory N-terminal domain. Raf-1 is activated in response to a variety of tyrosine kinase receptors as well as in response to pp60v-Src expression. Specifically, Raf-1 is phosphorylated in the catalytic domain at Ser 338 and, to a lesser extent, Ser 339. This phosphorylation requires the co-activation of PI 3-kinase and the Ras signaling pathway. Raf-1 is also phosphorylated on Tyr 340 and 341, which induces the phosphorylation of MEK. Phosphorylation of Ser 621 is essential for the catalytic activity of Raf-1 and downregulation by c-AMP-dependent protein kinase A (PKA). PKA also phosphorylates Raf-1 on Ser 43 and Ser 259. PKA phosphorylation of Ser 259 inhibits Raf-1 and decreases the phosphorylation necessary for Raf-1 activation at Ser 338.
Background References
1. K hler, M. et al. 2016. Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants. The EMBO journal. 35: 143-61.
2. El-Chaar, NN. et al. 2014. Genomic classification of the RAS network identifies a personalized treatment strategy for lung cancer. Molecular oncology. 8: 1339-54.
Sequence Similarity
Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.
Tissue Specificity
In skeletal muscle, isoform 1 is more abundant than isoform 2.
Post-translational Modification
Phosphorylation at Thr-269, Ser-338, Tyr-341, Thr-491 and Ser-494 results in its activation. Phosphorylation at Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2 results in its inactivation. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the complex containing protein phosphatase 1, SHOC2 and M-Ras/MRAS relieves inactivation, leading to stimulate RAF1 activity. Phosphorylation at Ser-338 by PAK1 and PAK5 and Ser-339 by PAK1 is required for its mitochondrial localization. Phosphorylation at Ser-621 in response to growth factor treatment stabilizes the protein, possibly by preventing proteasomal degradation. Phosphorylation at Ser-289, Ser-296, Ser-301, Ser-338 and Ser-621 are somehow linked to the methylation potential of cells. Treatment of cells with HGF in the presence of the methylation inhibitor 5'-methylthioadenosine (MTA) results in increased phosphorylation at Ser-338 and Ser-621 and decreased phosphorylation at Ser-296, Ser-301 and Ser-338. Dephosphorylation at Ser-338 by PPP5C results in an activity decrease.; Methylated at Arg-563 in response to EGF treatment. This modification leads to destabilization of the protein, possibly through proteasomal degradation.
Subcellular Location
Cytoplasm, Cell membrane, Mitochondrion, Nucleus.
Synonyms
c Raf antibody
C-raf antibody
C-Raf proto-oncogene, serine/threonine kinase antibody
CMD1NN antibody
Craf 1 transforming gene antibody
cRaf antibody
Craf1 transforming gene antibody
EC 2.7.11.1 antibody
kinase Raf1 antibody
Murine sarcoma 3611 oncogene 1 antibody
Expandc Raf antibody
C-raf antibody
C-Raf proto-oncogene, serine/threonine kinase antibody
CMD1NN antibody
Craf 1 transforming gene antibody
cRaf antibody
Craf1 transforming gene antibody
EC 2.7.11.1 antibody
kinase Raf1 antibody
Murine sarcoma 3611 oncogene 1 antibody
NS5 antibody
Oncogene MIL antibody
Oncogene RAF1 antibody
OTTHUMP00000160218 antibody
OTTHUMP00000207813 antibody
OTTHUMP00000209389 antibody
Protein kinase raf 1 antibody
Proto-oncogene c-RAF antibody
Raf 1 antibody
Raf 1 proto oncogene serine/threonine kinase antibody
RAF antibody
Raf proto oncogene serine/threonine protein kinase antibody
RAF proto-oncogene serine/threonine-protein kinase antibody
RAF-1 antibody
RAF1 antibody
RAF1_HUMAN antibody
Similar to murine leukemia viral (V-raf-1) oncogene homolog 1 antibody
TRANSFORMING REPLICATION-DEFECTIVE MURINE RETROVIRUS 3611-MSV antibody
v raf 1 murine leukemia viral oncogene homolog 1 antibody
v-raf murine sarcoma viral oncogene homolog 1 antibody
v-raf-1 murine leukemia viral oncogene-like protein 1 antibody
vraf1 murine leukemia viral oncogene homolog 1 antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of Phospho-Raf1 (S259) on different lysates with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/2,000 dilution.
Lane 1: HEK-293 cell lysate
Lane 2: HeLa cell lysate
Lane 3: NIH/3T3 cell lysate
Lane 4: C6 cell lysate
Lane 5: HEK-293 cell lysate, the membrane treated with λpp for 1 hour
Lysates/proteins at 20 µg/Lane.
Predicted band size: 73 kDa
Observed band size: 65 kDa
Exposure time: 59 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1612-87) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HEK-293 cells labeling Phospho-Raf1 (S259) with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunohistochemical analysis of paraffin-embedded human skeletal muscle tissue with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1612-87) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse skeletal muscle tissue with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1612-87) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat skeletal muscle tissue with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1612-87) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human testis tissue with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1612-87) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human tracheal tissue with Rabbit anti-Phospho-Raf1 (S259) antibody (ET1612-87) at 1/400 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1612-87) at 1/400 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Flow cytometric analysis of HEK-293 cells labeling Phospho-Raf1 (S259).
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1612-87, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Citation
-
Synthesis and Biological Evaluation of Novel Gemcitabine-Dexamethasone Hybrid as Potent Antitumor Agents against Esophageal Cancer
Journal: European Journal Of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2026.119252
IF: 6.7
Application: WB
Reactivity: Human
Publish date: 2026 Aug
-
Berberine Attenuates Hypertrophic Phenotype in RAF1-Mutant Induced Pluripotent Stem Cell-Derived Cardiomyocytes through Suppression of ERK5-Cyclin D1 Signaling
Journal: Cardiovascular Drugs and Therapy
DOI: 10.1007/s10557-026-07947-7
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2026 Aug
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Products with the same target and pathway
Phospho-Raf1 (S43) Recombinant Rabbit Monoclonal Antibody [SD087-05]
Application: WB
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Phospho-Raf1 (S621) Recombinant Rabbit Monoclonal Antibody [JJ085-05]
Application: WB,IHC-P
Reactivity: Human,Rat,Mouse
Conjugate: unconjugated
Phospho-Raf1 (S259) Recombinant Rabbit Monoclonal Antibody [SD85-07] - BSA and Azide free
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Raf1 Recombinant Rabbit Monoclonal Antibody [JJ086-06]
Application: WB
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated